A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis

Cited by (1,000)

Items 601–700 of 1,000

  1. S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma
    Ken Katono, Yuichi Sato, Makoto Kobayashi, Ryo Nagashio, Shinichiro Ryuge, Satoshi Igawa, Masaaki Ichinoe, Yoshiki Murakumo, Makoto Saegusa, Noriyuki Masuda · 2017 · OncoTargets and Therapy
  2. CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer
    Yuyi Wang, Li Tu, Chi Du, Xiaoxiao Xie, Yanyang Liu, Jiantao Wang, Zhixi Li, Ming Jiang, Dan Cao, Yan Xi et al. · 2018 · OncoTargets and Therapy
  3. Uev1A-Ubc13 promotes colorectal cancer metastasis through regulating CXCL1 expression via NF-кB activation
    Zhaojia Wu, Heather L. D. Neufeld, E. Torlakovic, W. Xiao · 2018 · OncoTarget
  4. Awakening of Dormant Breast Cancer Cells in the Bone Marrow
    Robert Wieder · 2023 · Cancers
  5. Metformin Synergizes with BCL-XL/BCL-2 Inhibitor ABT-263 to Induce Apoptosis Specifically in p53-Defective Cancer Cells
    Xinzhe Li, Bo Li, Zhenhong Ni, Peng Zhou, Bin Wang, Jintao He, Haojun Xiong, Fan Yang, Yaran Wu, Xilin Lyu et al. · 2017 · Molecular Cancer Therapeutics
  6. Curcumin interacts with sildenafil to kill GI tumor cells via endoplasmic reticulum stress and reactive oxygen/ nitrogen species
    Jane L. Roberts, Andrew Stewart Poklepovic, Laurence A. Booth · 2017 · Oncotarget
  7. Loss of zinc‐finger protein 143 contributes to tumour progression by interleukin‐8‐CXCR axis in colon cancer
    Vikas Kumar Verma, A Rome Paek, Beom-Kyu Choi, Eun Kyung Hong, Hye Jin You · 2019 · Journal of Cellular and Molecular Medicine
  8. Apoptotic Resistance of Metastatic Tumor Cells in Triple Negative Breast Cancer: Roles of Death Receptor-5
    Mohammad Kamalabadi‐Farahani, Mohammad Reza H. Najafabadi, Zahra Jabbarpour · 2019 · Asian Pacific Journal of Cancer Prevention
  9. Chromatin Remodeling in Response to BRCA2-Crisis
    Joshua James Gruber, Justin Chen, Benjamin S. Geller, Natalie Jäger, Andrew M. Lipchik, Guangwen Wang, Allison W. Kurian, James M. Ford, Michael P. Snyder · 2019 · Cell Reports
  10. Notch-Inflammation Networks in Regulation of Breast Cancer Progression
    Yulia Liubomirski, Adit Ben‐Baruch · 2020 · Cells
  11. Pentagalloyl glucose inhibits TNF‐α‐activated CXCL1/GRO-α expression and induces apoptosis‐related genes in triple-negative breast cancer cells
    Patricia Mendonca, Sumaih Alghamdi, Samia S. Messeha, Karam F. A. Soliman · 2021 · Scientific Reports
  12. Breast cancer brain metastasis: from etiology to state-of-the-art modeling
    Mohammad Kamalabadi‐Farahani, Maliheh Gharibshahian, Alireza Rezvani, Ahmad Vaez · 2023 · Journal of Biological Engineering
  13. ACAT1 deficiency in myeloid cells promotes glioblastoma progression by enhancing the accumulation of myeloid-derived suppressor cells
    Mingjin Wang, Weida Wang, Shen You, Zhenyan Hou, Ming Ji, Nina Xue, Tingting Du, Xiao‐Guang Chen, Jing Jin · 2023 · Acta Pharmaceutica Sinica B
  14. Screening for Anti‐cancer Drugs inDrosophila
    Helena E. Richardson, Lee F. Willoughby, Patrick Orson Humbert · 2015 · Encyclopedia of Life Sciences
  15. Reprogramming cellular senescence and aging clocks for advanced cancer immunotherapy
    Huiting Yang, Dong Liu, Liewang Qiu, Rui Wang, Chuchu Zhang, Danqing Yu, Qingping Zhong, Nitta Yuki, Zhentao Song, Τao Zhu et al. · 2025 · Molecular Cancer
  16. For robust big data analyses: a collection of 150 important pro-metastatic genes
    Yan Mei, Jun-Ping Yang, Chao-Nan Qian · 2017 · 癌症:英文版
  17. Histone methyltransferase SETD2 inhibits tumor growth via suppressing CXCL1-mediated activation of cell cycle in lung adenocarcinoma
    You Zhou, Xiao Wei Zheng, Bin Xu, Haifeng Deng, Lujun Chen, Jingting Jiang · 2020 · Aging
  18. Mesenchymal stem cells and cancer‐associated fibroblasts as a therapeutic strategy for breast cancer
    Francisco Raúl Borzone, María Belén Giorello, María Cecilia Sanmartin, Gustavo Yannarelli, Leandro Marcelo Martinez, Norma Alejandra Chasseing · 2022 · British Journal of Pharmacology
  19. Targeting inflammation in pancreatic cancer: Clinical translation
    Colin William Steele, Nina Angharad Kaur Gill, Nigel Balfour Jamieson, Christopher Ross Carter · 2016 · World Journal of Gastrointestinal Oncology
  20. Roles of omental and bone marrow adipocytes in tumor biology
    Yoon Jin Cha, Ja Seung Koo · 2019 · Adipocyte
  21. HCK promotes glioblastoma progression by TGFβ signaling
    Zhenlin Wang, Chenting Ying, Anke Zhang, Houshi Xu, Yang Jiang, Meiqing Lou · 2020 · Bioscience Reports
  22. Cancer-preventive effect of phenethyl isothiocyanate through tumor microenvironment regulation in a colorectal cancer stem cell xenograft model
    Ji Min Shin, Eunbi Lim, Yoon Shin Cho, Chu Won Nho · 2021 · Phytomedicine
  23. S100A8-Mediated Inflammatory Signaling Drives Colorectal Cancer Progression via the CXCL5/CXCR2 Axis
    Libin Chen, Peng Shu, Xuemei Zhang, Shuyu Ye, Li Tian, Shourong Shen, Jian Ma, Feiyan Ai, Xiayu Li · 2024 · Journal of Cancer
  24. Insights on the role of the chemokine CCL8 in pathology
    Bernardo Chavez, Hippokratis Kiaris · 2025 · Cellular Signalling
  25. p21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia
    Cristina Sáiz-Ladera, Maria Fernanda Lara, Marina Inmaculada Garin, S Ruiz, M Santos, Corina Lorz, Ramón García‐Escudero, Mónica Martínez‐Fernández, Ana Bravo, Óscar Fernández-Capetillo et al. · 2013 · Oncogene
  26. Over-expression of CXCL2 is associated with poor prognosis in patients with ovarian cancer
    Fenghua Zhang, Jingting Jiang, Bin Xu, Yun Xu, Changping Wu · 2021 · Medicine
  27. Antitumor Efficacy of CC Motif Chemokine Ligand 19 in Colorectal Cancer
    Jun Lü, Jingkun Zhao, Hao Feng, Puxiongzhi Wang, Zhuo Zhang, Yaping Zong, Junjun Ma, Minhua Zheng, Aiguo Lu · 2014 · Digestive Diseases and Sciences
  28. Curcumin Inhibits 5‐Fluorouracil‐induced Up‐regulation of CXCL 1 and CXCL 2 of the Colon Associated with Attenuation of Diarrhoea Development
    Hiroyasu Sakai, Yuki Kai, Aya Oguchi, Minami Kimura, Shoko Tabata, Miyabi Yaegashi, Taiki Saito, Ken Sato, Fumiaki Sato, Tetsuro Yumoto et al. · 2016 · Basic & Clinical Pharmacology & Toxicology
  29. Rapid identification of antimicrometastases drugs using integrated model systems with two dimensional monolayer, three dimensional spheroids, and zebrafish xenotransplantation tumors
    Afu Fu, Yu Ming Peh, Weida Ngan, Na Wei, Kathy Qian Luo · 2018 · Biotechnology and Bioengineering
  30. Aiding and Abetting: How the Tumor Microenvironment Protects Cancer from Chemotherapy
    Eleanor C. Fiedler, Michael T. Hemann · 2018 · Annual Review of Cancer Biology
  31. Cancer-associated fibroblasts promote cell growth by activating ERK5/PD-L1 signaling axis in colorectal cancer
    Mengyan Zhang, Ran Shi, Zhongying Guo, Jingdong He · 2020 · Pathology - Research and Practice
  32. MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signaling
    Zheng-Jun Zhou, Chu-Bin Luo, Hao-Yang Xin, Zhi-Qiang Hu, Gui-Qi Zhu, Jia Li, Shao-Lai Zhou · 2020 · npj Genomic Medicine
  33. Targeting Oncoimmune Drivers of Cancer Metastasis
    Chie Kudo‐Saito, Yukinori Ozaki, Hiroshi Imazeki, Hideyuki Hayashi, Jun Masuda, Hiroki Ozawa, Yamato Ogiwara · 2021 · Cancers
  34. A Normalization-Free and Nonparametric Method Sharpens Large-Scale Transcriptome Analysis and Reveals Common Gene Alteration Patterns in Cancers
    Qi-Gang Li, Yonghan He, Huan Wu, Cuiping Yang, Shao-Yan Pu, Songqing Fan, Liping Jiang, Qiushuo Shen, Xiaoxiong Wang, Xiao‐Qiong Chen et al. · 2017 · Theranostics
  35. The TGFα-EGFR-Akt signaling axis plays a role in enhancing proinflammatory chemokines in triple-negative breast cancer cells
    Rosa Mistica C. Ignacio, Carla R. Gibbs, Eun-Sook Lee, Deok‐Soo Son · 2018 · Oncotarget
  36. High expression level of CXCL1/GROα is linked to advanced stage and worse survival in uterine cervical cancer and facilitates tumor cell malignant processes
    Xiaxia Man, Xiaolin Yang, Zhentong Wei, Yuying Tan, Wanying Li, Hongjuan Jin, Baogang Wang · 2022 · BMC Cancer
  37. Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets
    Aiyuan Guo, Jingwei Zhang, Yuqiu Tian, Yun Peng, Peng Luo, Jian Zhang, Zaoqu Liu, Wantao Wu, Hao Zhang, Quan Cheng · 2022 · Frontiers in Immunology
  38. Targeting ARF1-IQGAP1 interaction to suppress colorectal cancer metastasis and vemurafenib resistance
    Huifang Hu, Gui‐Bin Gao, Xuan He, Yuying Li, Yang‐Jia Li, Bin Li, Yun-long Pan, Yang Wang, Qing‐Yu He · 2022 · Journal of Advanced Research
  39. LINC00982-encoded protein PRDM16-DT regulates CHEK2 splicing to suppress colorectal cancer metastasis and chemoresistance
    Huifang Hu, Lei Han, Jiaying Fu, Xuan He, Ji-Feng Tan, Qing-Ping Chen, Jing-Ru Han, Qing‐Yu He · 2024 · Theranostics
  40. Omega-3 fatty acids: molecular weapons against chemoresistance in breast cancer
    Vittoria Marchio, Giuseppina Augimeri, Catia Morelli, Adele Vivacqua, Cinzia Giordano, Stefania Catalano, Diego Sisci, Ines Barone, Daniela Bonofiglio · 2025 · Cellular & Molecular Biology Letters
  41. Extracellular Vesicles – Powerful Markers of Cancer EVolution
    Joana Carvalho, Carla Oliveíra · 2015 · Frontiers in Immunology
  42. Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists
    Nuray Erin, Esra Nizam, Gamze Tanrιöver, Sadi Köksoy · 2015 · Breast Cancer Research and Treatment
  43. The Potential for Connexin Hemichannels to Drive Breast Cancer Progression through Regulation of the Inflammatory Response
    Joshua Matthew Rhett, Elizabeth Shinmay Yeh · 2018 · International Journal of Molecular Sciences
  44. Nicaraven Attenuates Postoperative Systemic Inflammatory Responses-Induced Tumor Metastasis
    Xu Zhang, Takahito Moriwaki, Tsuyoshi Kawabata, Shinji Goto, Ke-Xiang Liu, Chang‐Ying Guo, Tao‐Sheng Li · 2019 · Annals of Surgical Oncology
  45. HRD1 sensitizes breast cancer cells to Tamoxifen by promoting S100A8 degradation
    Yanyan Wang, Aibin Guo, Xiubin Liang, Min Li, Ming Shi, Yan Li, Gareth N. Jenkins, Xia-Wen Lin, Xuefei Wei, ZhiJun Jia et al. · 2017 · Oncotarget
  46. Tools for visualizing cell–cell ‘interactomes’
    William Porterfield, Jennifer A. Prescher · 2014 · Current Opinion in Chemical Biology
  47. IL-21 receptor signaling is essential for control of hepatocellular carcinoma growth and immunological memory for tumor challenge
    Xinchun Zheng, Yang Zhou, Xuan Yi, Chengcong Chen, Chunhua Wen, Guofu Ye, Xiaoyi Li, Libo Tang, Xiaoyong Zhang, Fuqiang Yang et al. · 2018 · OncoImmunology
  48. Neddylation Regulates Macrophages and Implications for Cancer Therapy
    Yanyu Jiang, Lihui Li, Li Yan, Guangwei Liu, Robert M. Hoffman, Lijun Jia · 2021 · Frontiers in Cell and Developmental Biology
  49. Kinectin 1 promotes the growth of triple-negative breast cancer via directly co-activating NF-kappaB/p65 and enhancing its transcriptional activity
    Lin Gao, Shanze Chen, Malin Hong, Wenbin Zhou, Bilan Wang, Junying Qiu, Jinquan Xia, Pan Zhao, Li Fu, Jigang Wang et al. · 2021 · Signal Transduction and Targeted Therapy
  50. Imaging innate immunity*
    Anika Grüneboom, Oliver Aust, Zülal Cibir, Flora Weber, Dirk Matthias Hermann, Matthias Gunzer · 2021 · Immunological Reviews
  51. p53 Signaling on Microenvironment and Its Contribution to Tissue Chemoresistance
    Leonel Cardozo de Menezes e Souza, Anderson Faletti, Carla Pires Veríssimo, Mariana Paranhos Stelling, Helena L. Borges · 2022 · Membranes
  52. Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas
    Paul K. Paik, Jia Luo, Ni Ai, Rachel Y. Kim, Linda Su Hyun Ahn, Anup Biswas, Courtney Coker, Wanchao Ma, Phillip Wong, Darren J. Buonocore et al. · 2022 · Nature Communications
  53. Live-Cell Imaging of Endogenous RNA with a Genetically Encoded Fluorogenic Allosteric Aptamer
    Yan Peng, Linjuan Shu, Xiongfei Deng, Xin Huang, Xianming Mo, Feng Du, Zhuo Tang · 2023 · Analytical Chemistry
  54. Forces at play: exploring factors affecting the cancer metastasis
    Farooq Riaz, Jing Zhang, Fan Pan · 2024 · Frontiers in Immunology
  55. Is carcinoma a mesenchymal disease? The role of the stromal microenvironment in carcinogenesis
    Chris Hemmings · 2013 · Pathology
  56. Involvement of NF-ΚB and HSP70 signaling pathways in the apoptosis of MDA-MB-231 cells induced by a prenylated xanthone compound, α-mangostin, from Cratoxylum arborescens
    Mohamed Yousif Ibrahim, Hapipah Mohd Ali, Najihah Mohd Hashim, Syam Mohan, Siddig İbrahim Abdelwahab, Behnam Kamalıdehghan, Mostafa Ghaderian, Firouzeh Dehghan, Landa Zeenelabdin Ali, Hamed Karimian et al. · 2014 · Drug Design Development and Therapy · Retracted
  57. RETRACTED: Ca2+/calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer
    Shoujie Chai, Yingying Qian, Jingfen Tang, Zhuyu Liang, Min Zhang, Jingxing Si, Xiuzhen Li, Wengdong Huang, Rongzhen Xu, Kai Wang · 2013 · Cancer Letters · Retracted
  58. Diesel exhaust particle promotes tumor lung metastasis via the induction of BLT1-mediated neutrophilic lung inflammation
    Wenjing Li, Ting Liu, Yingluo Xiong, Jiaoyan Lv, Xinyi Cui, Rui He · 2018 · Cytokine
  59. Unique Pro-Inflammatory Response of Macrophages during Apoptotic Cancer Cell Clearance
    Veronica Mendoza‐Reinoso, Dah Youn Baek, Adrianne Kurutz, John R. Rubin, Amy J. Koh, Laurie K. McCauley, Hernan Roca · 2020 · Cells
  60. (20S)G-Rh2 Inhibits NF-κB Regulated Epithelial-Mesenchymal Transition by Targeting Annexin A2
    Yushi Wang, He Li, Yang Li, Shiyin Zhang, Ying‐Hua Jin · 2020 · Biomolecules
  61. Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single‐cell transcriptomic analysis: Implications for distinct immunotherapy outcomes
    Xinyun Fang, Dianke Li, Shiyue Wan, Junjie Hu, Peng Zhang, Dai Jie, Linsong Chen, Gening Jiang, Nan Song · 2024 · The Journal of Gene Medicine
  62. CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer
    Sipei Nie, Yicong Wan, Hui Wang, Jinhui Liu, Jing Yang, Rui Sun, Huangyang Meng, Xiaolin Ma, Yi Jiang, Wenjun Cheng · 2021 · Journal of Ovarian Research
  63. Capturing tumour heterogeneity in pre- and post-chemotherapy colorectal cancer ascites-derived cells using single-cell RNA-sequencing
    Tiraput Poonpanichakul, Meng‐Shin Shiao, Natnicha Jiravejchakul, Ponpan Matangkasombut, Ekaphop Sirachainan, Varodom Charoensawan, Natini Jinawath · 2021 · Bioscience Reports
  64. KLK6/PAR1 Axis Promotes Tumor Growth and Metastasis by Regulating Cross-Talk between Tumor Cells and Macrophages
    Yo Sep Hwang, Hee Jun Cho, Eun Sun Park, Jeewon Lim, Hyang Ran Yoon, Jong-Tae Kim, Suk Ran Yoon, Haiyoung Jung, Yong‐Kyung Choe, Yong‐Hoon Kim et al. · 2022 · Cells
  65. Galectin-7 reprograms skin carcinogenesis by fostering innate immune evasive programs
    Nicolás A. Pinto, Martı́n C. Abba, Lorena Laporte, Juan Manuel Pérez Sáez, Ada Gabriela Blidner, Nicolás I. Torres, Rosa María Morales, Sabrina G. Gatto, Camila Agustina Bach, Florencia Veigas et al. · 2023 · Cell Death and Differentiation
  66. Inflammatory Molecule, PSGL-1 , Deficiency Activates Macrophages to Promote Colorectal Cancer Growth through NFκB Signaling
    Jiangchao Li, Zeqi Zhou, Xiaohan Zhang, Zheng Li, Dan He, Yuxiang Ye, Qian-Qian Zhang, Cuiling Qi, Xiaodong He, Yu Chen et al. · 2017 · Molecular Cancer Research · Retracted
  67. Epithelial-mesenchymal transition induced by GRO-α-CXCR2 promotes bladder cancer recurrence after intravesical chemotherapy
    Lu Chen, Xiuwu Pan, Hai Huang, Yi Gao, Qi-Wei Yang, Linhui Wang, Xingang Cui, Danfeng Xu · 2017 · Oncotarget
  68. IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways
    Xiaomeng Wang, Jiali Xu, Jin Chen, Shidai Jin, Jiaqi Yao, Tongfu Yu, Wei Ting Wang, Renhua Guo · 2019 · Frontiers in Oncology
  69. Phosphorylation of pericyte FAK-Y861 affects tumour cell apoptosis and tumour blood vessel regression
    Delphine M. Lees, Louise E. Reynolds, Ana‐Rita Pedrosa, Marina Roy-Luzarraga, Kairbaan Hodivala‐Dilke · 2021 · Angiogenesis
  70. A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment
    Daniel Ryan, Abhilasha Sinha, Danielle R. Bogan, Joanna Davida Davies, Jim Koziol, Wael M. ElShamy · 2017 · Oncotarget
  71. The prognostic value of CXC chemokine receptor 2 (CXCR2) in cancers: a meta-analysis
    Bingbing Qiao, Wenqin Luo, Yanna Liu, Jing Wang, Chuan Liu, Zhao Liu, Sizhe Chen, Jingjing Gu, Xiaolong Qi, Tongwei Wu · 2017 · Oncotarget
  72. Function and Regulation of Bone Marrow Adipose Tissue in Health and Disease: State of the Field and Clinical Considerations
    Zhang, Xiao, Tian, Linda, Majumdar, Anurag, Scheller, Erica L. · 2024 · Comprehensive Physiology
  73. Stability of cytokines in supernatants of stimulated mouse immune cells
    Gül Özbey, Reginald M. Gorczynski, Nuray Erin · 2014 · European Cytokine Network
  74. p53 Promotes Cytokine Expression in Melanoma to Regulate Drug Resistance and Migration
    Pinakin Pandya, Lyubov Kublo, Jacob Stewart-Ornstein · 2022 · Cells
  75. DNA Methylation-Mediated Overexpression of CXCL1 in Helicobacter pylori-Induced Gastric Cancer: In Silico- and In Vitro-Based Identification of a Potential Biomarker for Carcinogenesis
    Jibran Sualeh Muhammad, Shaista Manzoor, Zheng‐Guo Cui, Ghalia Khoder · 2023 · International Journal of Molecular Sciences
  76. Combined in vitro/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistance
    Gang Yan, Meiou Dai, Sophie Poulet, Ni Wang, Julien Boudreault, Girija Daliah, Suhad Ali, J J Lebrun · 2023 · Oncogenesis
  77. Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer
    Liyan Lao, Siting Fan, Erwei Song · 2017 · Advances in experimental medicine and biology
  78. Value of CXCL8–CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study
    Ruoxi Wang, Peng Ji, Yue Gong, Zhi‐Ming Shao, Sheng Chen · 2020 · Breast Cancer Research and Treatment
  79. Research Progress About Glioma Stem Cells in the Immune Microenvironment of Glioma
    Xiangyu Li, Ming Liu, Junfeng Zhao, Tong Ren, Xin Yan, Lijun Zhang, Xun Wang · 2021 · Frontiers in Pharmacology
  80. Anti-inflammatory effect of Marchantin M contributes to sensitization of prostate cancer cells to docetaxel
    Leilei Niu, Jingti Deng, Fanghua Zhu, Nan Zhou, Keli Tian, Huiqing Yuan, Hong‐Xiang Lou · 2014 · Cancer Letters
  81. PLAG Exerts Anti-Metastatic Effects by Interfering with Neutrophil Elastase/PAR2/EGFR Signaling in A549 Lung Cancer Orthotopic Model
    Guen Tae Kim, Kyu Woong Hahn, Sun Young Yoon, Ki‐Young Sohn, Jae Wha Kim · 2020 · Cancers
  82. Small extracellular vesicles deliver TGF‐β1 and promote adriamycin resistance in breast cancer cells
    Chunli Tan, Wenbo Sun, Zhi Xu, Shuyi Zhu, Weizi Hu, Xiumei Wang, Yanyan Zhang, Guangqin Zhang, Zibin Wang, Yong Xu et al. · 2021 · Molecular Oncology
  83. Continuous Inflammatory Stimulation Leads via Metabolic Plasticity to a Prometastatic Phenotype in Triple-Negative Breast Cancer Cells
    Dina Morein, Linor Rubinstein-Achiasaf, Hadar Brayer, Orly Dorot, Edward Pichinuk, Hagar Ben-Yaakov, Tsipi Meshel, Metsada Pasmanik‐Chor, Adit Ben‐Baruch · 2021 · Cells
  84. TICAM-1/TRIF associates with Act1 and suppresses IL-17 receptor–mediated inflammatory responses
    Yusuke Miyashita, Takahisa Kouwaki, Hirotake Tsukamoto, Masaaki Okamoto, Kimitoshi Nakamura, Hiroyuki Oshiumi · 2021 · Life Science Alliance
  85. Enabling CAR-T cells for solid tumors: Rage against the suppressive tumor microenvironment
    Asier Antoñana-Vildosola, Samanta Romina Zanetti, Asís Palazón · 2022 · International review of cytology
  86. Natural small molecule self-assembled hydrogel inhibited tumor growth and lung metastasis of 4T1 breast cancer by regulating the CXCL1/2-S100A8/9 axis
    Yuqin Yang, Desheng Cai, Yisong Shu, Zhihua Yuan, Wenmin Pi, Yaozhi Zhang, Jihui Lu, Jingyi Jiao, Xuehao Cheng, Feifei Li et al. · 2022 · Materials & Design
  87. 7S,15R-Dihydroxy-16S,17S-epoxy-docosapentaenoic Acid Overcomes Chemoresistance of 5-Fluorouracil by Suppressing the Infiltration of Tumor-Associated Macrophages and Inhibiting the Activation of Cancer Stem Cells in a Colorectal Cancer Xenograft Model
    Yan Su, Hack Sun Choi, Jong Hyun Choi, Hee-Sik Kim, Yong‐Suk Jang, Jeong‐Woo Seo · 2023 · Marine Drugs
  88. CXCL1 and CXCL2 link metastasis and chemoresistance
    Pamela Feliciano · 2012 · Nature Genetics
  89. Plac1 Is a Key Regulator of the Inflammatory Response and Immune Tolerance In Mammary Tumorigenesis
    Hongyan Yuan, Xiaoyi Wang, Chunmei Shi, Lü Jin, Jianxia Hu, Alston Zhang, James Li, Nairuthya Vijayendra, Venkata Doodala, Spencer Weiss et al. · 2018 · Scientific Reports
  90. Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response
    Dmytro Dvornikov, Marc Andre Schneider, Sebastian Ohse, Magdalena Szczygieł, I. Titkova, Marcus Rosenblatt, Thomas Muley, Arne Warth, Felix J.F. Herth, Hendrik Dienemann et al. · 2018 · Scientific Reports
  91. Microbiomes and Resistomes in Biopsy Tissue and Intestinal Lavage Fluid of Colorectal Cancer
    Yumeng Yuan, Yihuan Chen, Fen Yao, Mi Zeng, Qingdong Xie, Muhammad Shafiq, Sohail Muhammad Noman, Xiaoyang Jiao · 2021 · Frontiers in Cell and Developmental Biology
  92. Altered Gene Expression in Dioxin-Like and Non-Dioxin-Like PCB Exposed Peripheral Blood Mononuclear Cells
    Marike M. Leijs, Lin Gan, Patrick De Boever, André Esser, Philipp M. Amann, Patrick Ziegler, Katharina Fietkau, Thomas Schettgen, Thomas Kraus, Hans Friedrich Merk et al. · 2019 · International Journal of Environmental Research and Public Health
  93. Correction: Awakened by Cellular Stress: Isolation and Characterization of a Novel Population of Pluripotent Stem Cells Derived from Human Adipose Tissue
    Saleh G. Heneidi, Ariel A. Simerman, Erica Keller, Prapti Singh, Xinmin Li, Daniel Anthony Dumesic, Gregorio Daniel Chazenbalk · 2013 · PLoS ONE
  94. ODSEI Chip: An Open 3D Microfluidic Platform for Studying Tumor Spheroid‐Endothelial Interactions
    Jooyoung Ro, Junyoung Kim, Juhee Park, Yong‐Jun Choi, Yoon‐Kyoung Cho · 2025 · Advanced Science
  95. Altered Expression of Secreted Mediator Genes That Mediate Aggressive Breast Cancer Metastasis to Distant Organs
    A. Maiti, I. Okano, M. Oshi, M. Okano, W. Tian, T. Kawaguchi, E. Katsuta, K. Takabe, Li Yan, S. Patnaik et al. · 2020 · Cancers
  96. Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor Microenvironment
    Larissa S. Carnevalli, Hormas Ghadially, Simon T. Barry · 2021 · Frontiers in Immunology
  97. S100A8/A9 as a risk factor for breast cancer negatively regulated by DACH1
    Xiaojun Zhang, Mengke Niu, Tianye Li, Yuze Wu, Jinnan Gao, Ming Yi, Kongming Wu · 2023 · Biomarker Research
  98. Targeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosis
    Federico Fondelli, Jana Willemyns, Roger Domenech-Garcia, María José Mansilla, Gerard Godoy‐Tena, Anna Guiomar Ferreté-Bonastre, Alex Agúndez-Moreno, Silvia Presas‐Rodríguez, Cristina M. Ramo-Tello, Esteban Ballestar et al. · 2024 · Journal of Clinical Investigation
  99. Pao Pereira Extract Suppresses Castration-Resistant Prostate Cancer Cell Growth, Survival, and Invasion Through Inhibition of NFκB Signaling
    Cunjie Chang, Wei Zhao, Bingxian Xie, Yongming Deng, Tao Han, Yangyan Cui, Yun-Dong Dai, Zhen Zhang, Jimin Gao, Hongqian Guo et al. · 2013 · Integrative Cancer Therapies
  100. Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer
    Xiaomin Fu, Yong Zhang, Jing Yang, Yalong Qi, Yue Ming, Miaomiao Sun, Yiman Shang, Yonghao Yang, Xiaoyan Zhu, Quanli Gao · 2018 · OncoTargets and Therapy